Skip to content

Breathing platform for relaxation

Take-home study assessing the usability of a breathing platform for relaxation in healthy participants

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12618000709246
Enrollment
10
Registered
2018-05-01
Start date
2018-06-11
Completion date
2018-06-14
Last updated
2019-01-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

This study aims to assess the usability of a breathing platform for relaxation. Healthy participants will be used and required to fill in questionnaires during and at the completion of the study based on the ease of use of the system.

Interventions

The breathing platform will use a continuous positive air pressure (CPAP) device controlled by an app. Device and mobile phone (to run app) will be provided to participants by investigators on day 1 of the study. The device settings will include a pressure delivery between 4 and 20 cmH2O. Treatment session will involve starting their CPAP (with the 'on' button) and using the app for breathing instructions. Intended frequency of intervention involves 10-30 mins of therapy per day, for 4 days. Fee

The breathing platform will use a continuous positive air pressure (CPAP) device controlled by an app. Device and mobile phone (to run app) will be provided to participants by investigators on day 1 of the study. The device settings will include a pressure delivery between 4 and 20 cmH2O. Treatment session will involve starting their CPAP (with the 'on' button) and using the app for breathing instructions. Intended frequency of intervention involves 10-30 mins of therapy per day, for 4 days. Feedback & compliance will be logged in interview at day 5.

Sponsors

ResMed
Lead SponsorCommercial sector/Industry

Study design

Allocation
Randomised controlled trial
Primary purpose
Treatment

Eligibility

Sex/Gender
All
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

• Participants are willing to give written, informed consent • Participants are healthy adults • Participants are able to comprehend and speak English • Participants are at least 18 years of age

Exclusion criteria

• Participants who are/may be pregnant or lactating • Participants that have a pre-existing lung disease/ condition that would predispose them to pneumothorax (for example: COPD; lung cancer; fibrosis of the lungs; recent (< 2years) case of pneumonia or lung infection; lung injury) • Participants who are unsuitable for the inclusion at the discretion of the investigator

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026